Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 15 years of age or older at the time of joining the trial
- People who have been diagnosed with ALL (acute lymphoblastic leukemia) or T-cell lymphoblastic lymphoma (a type of blood cancer)
- People who are currently being treated with a treatment plan that includes a maintenance phase using two medicines called mercaptopurine and methotrexate (for example, a plan called CALGB 10403) — enrollment happens before or at the start of the maintenance phase, though people in the early pilot phase may have already started maintenance, as long as their maintenance treatment is not scheduled to end before the 28-day pilot period is over
- People whose preferred language for medical communication is something other than English are still eligible, as text messages used in the trial can be sent in the patient's preferred language
Who may not be able to join:
- People where neither the patient nor their caregiver has a mobile phone that can receive text messages
- People who do not wish to take part in the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Austin Wesevich, University of Chicago
Phone: 1-855-702-8222
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To compare adherence to oral chemotherapy between study groups for first treatment cycle (Efficacy Phase); Feasibility of text message interventions to improve adherence to oral chemotherapy (Pilot Phase)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.